TreeWAS
Search
Variant clusters
Hospitalization Episode Statistics (HES)
Genetic variants: 36,212
Diagnostic terms: × 19,155
Association results: = 693,640,860
Self-Reported Statistics (SRS)
Genetic variants: 28,458
Diagnostic terms: × 474
Association results: = 13,489,092
About
Frequently Asked Questions
Citation
Download association data
for this variant in csv format
Share this page

Variant-specific associations

rs9368501
log Bayes Factor = 54.1814
Chromosome 6   position 27,295,082  (GRCh37) Explore rs9368501 on Ensembl!

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?
Associations at terminal nodes are shown if p(effect) ≥
Click here to show this figure without filtering.
Click on a node to zoom (except terminal nodes).
Download this figure in format
Results table
Term Risk
posterior probability
 No effect
posterior probability
 Protective
posterior probability
  
E83.1 Disorders of iron metabolism
0.000 0.000 1.000
K90.0 Coeliac disease
1.000 0.000 0.000
K90 Intestinal malabsorption
0.552 0.448 0.000
K90.4 Malabsorption due to intolerance, not elsewhere classified
0.511 0.489 0.000
K90.3 Pancreatic steatorrhoea
0.396 0.604 0.000
K90.2 Blind loop syndrome, not elsewhere classified
0.396 0.604 0.000
K90.1 Tropical sprue
0.396 0.604 0.000
K90.9 Intestinal malabsorption, unspecified
0.351 0.649 0.000
I83.9 Varicose veins of lower extremities without ulcer or inflammation
0.000 0.674 0.326
N40 Hyperplasia of prostate
0.000 0.709 0.291
K90.8 Other intestinal malabsorption
0.270 0.730 0.000
E83 Disorders of mineral metabolism
0.000 0.843 0.157
E83.3 Disorders of phosphorus metabolism
0.000 0.873 0.127
E83.9 Disorder of mineral metabolism, unspecified
0.000 0.887 0.112
E83.8 Other disorders of mineral metabolism
0.000 0.887 0.112
E83.2 Disorders of zinc metabolism
0.000 0.887 0.112
E83.0 Disorders of copper metabolism
0.000 0.887 0.112
T39.1 4-Aminophenol derivatives
0.000 0.896 0.104
I83 Varicose veins of lower extremities
0.000 0.906 0.094
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics
0.000 0.916 0.084
I83.0 Varicose veins of lower extremities with ulcer
0.000 0.919 0.081
E83.4 Disorders of magnesium metabolism
0.000 0.922 0.078
T39.0 Salicylates
0.000 0.925 0.075
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified
0.000 0.930 0.070
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified
0.000 0.931 0.068
T39.4 Antirheumatics, not elsewhere classified
0.000 0.939 0.060
T39.2 Pyrazolone derivatives
0.000 0.939 0.060
M75.1 Rotator cuff syndrome
0.059 0.941 0.000
I83.1 Varicose veins of lower extremities with inflammation
0.000 0.950 0.050
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]
0.000 0.950 0.050
M75 Shoulder lesions
0.046 0.954 0.000
M75.4 Impingement syndrome of shoulder
0.045 0.955 0.000
S02.40 Fracture of malar and maxillary bones (closed)
0.043 0.957 0.000
M75.2 Bicipital tendinitis
0.038 0.962 0.000
M75.8 Other shoulder lesions
0.037 0.963 0.000
K90-K93 Other diseases of the digestive system
0.036 0.964 0.000
S02.4 Fracture of malar and maxillary bones
0.036 0.964 0.000
M75.0 Adhesive capsulitis of shoulder
0.036 0.964 0.000
S02.50 Fracture of tooth (closed)
0.035 0.965 0.000
I83.2 Varicose veins of lower extremities with both ulcer and inflammation
0.001 0.966 0.033
S02.5 Fracture of tooth
0.033 0.967 0.000
M75.3 Calcific tendinitis of shoulder
0.032 0.968 0.000
S02 Fracture of skull and facial bones
0.031 0.969 0.000
M75.81 Other shoulder lesions, right shoulder
0.030 0.970 0.000
M75.5 Bursitis of shoulder
0.029 0.971 0.000
T42.6 Other antiepileptic and sedative-hypnotic drugs
0.000 0.973 0.027
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs
0.000 0.973 0.027
S02.8 Fractures of other skull and facial bones
0.026 0.974 0.000
K93 Disorders of other digestive organs in diseases classified elsewhere
0.026 0.974 0.000
S02.2 Fracture of nasal bones
0.026 0.974 0.000
T42.0 Hydantoin derivatives
0.000 0.975 0.025
T42.4 Benzodiazepines
0.000 0.975 0.025
M67.8 Other specified disorders of synovium and tendon
0.025 0.975 0.000
S02.41 Fracture of malar and maxillary bones (open)
0.024 0.976 0.000
S02.7 Multiple fractures involving skull and facial bones
0.024 0.976 0.000
S02.51 Fracture of tooth (open)
0.023 0.976 0.000
T36-T50 Poisoning by drugs, medicaments and biological substances
0.000 0.977 0.023
S02.80 Fractures of other skull and facial bones (closed)
0.023 0.977 0.000
S02.3 Fracture of orbital floor
0.023 0.977 0.000
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified
0.000 0.978 0.022
S02.20 Fracture of nasal bones (closed)
0.022 0.978 0.000
S02.9 Fracture of skull and facial bones, part unspecified
0.020 0.980 0.000
T42.5 Mixed antiepileptics, not elsewhere classified
0.000 0.980 0.020
T42.2 Succinimides and oxazolidinediones
0.000 0.980 0.020
S02.0 Fracture of vault of skull
0.020 0.980 0.000
T42.1 Iminostilbenes
0.000 0.980 0.020
S02.21 Fracture of nasal bones (open)
0.019 0.981 0.000
S02.81 Fractures of other skull and facial bones (open)
0.019 0.981 0.000
S02.6 Fracture of mandible
0.019 0.981 0.000
K93.8 Disorders of other specified digestive organs in diseases classified elsewhere
0.019 0.981 0.000
K93.1 Megacolon in Chagas' disease
0.019 0.981 0.000
K93.0 Tuberculous disorders of intestines, peritoneum and mesenteric glands
0.019 0.981 0.000
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]
0.000 0.981 0.019
S02.70 Multiple fractures involving skull and facial bones (closed)
0.018 0.981 0.000
M75.9 Shoulder lesion, unspecified
0.017 0.982 0.000
T37 Poisoning by other systemic anti-infectives and antiparasitics
0.000 0.982 0.017
S02.71 Multiple fractures involving skull and facial bones (open)
0.017 0.983 0.000
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances
0.000 0.983 0.017
T40.2 Other opioids
0.000 0.983 0.017
S02.30 Fracture of orbital floor (closed)
0.017 0.983 0.000
S02.31 Fracture of orbital floor (open)
0.016 0.983 0.000
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs
0.000 0.984 0.016
T41 Poisoning by anaesthetics and therapeutic gases
0.000 0.984 0.016
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants
0.000 0.984 0.016
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system
0.000 0.984 0.016
T42.3 Barbiturates
0.000 0.985 0.015
T36 Poisoning by systemic antibiotics
0.000 0.985 0.015
S02.91 Fracture of skull and facial bones, part unspecified (open)
0.015 0.985 0.000
T50.8 Diagnostic agents
0.000 0.985 0.015
N41.1 Chronic prostatitis
0.000 0.985 0.015
M67 Other disorders of synovium and tendon
0.015 0.985 0.000
N40-N51 Diseases of male genital organs
0.000 0.986 0.014
S02.01 Fracture of vault of skull (open)
0.014 0.986 0.000
S02.61 Fracture of mandible (open)
0.014 0.986 0.000
N41 Inflammatory diseases of prostate
0.000 0.986 0.014
S02.1 Fracture of base of skull
0.014 0.986 0.000
T40.5 Cocaine
0.000 0.986 0.014
T50.4 Drugs affecting uric acid metabolism
0.000 0.986 0.014
T40.9 Other and unspecified psychodysleptics [hallucinogens]
0.000 0.986 0.014
T40.8 Lysergide [LSD]
0.000 0.986 0.014
T40.7 Cannabis (derivatives)
0.000 0.986 0.014
T40.3 Methadone
0.000 0.986 0.014
T40.0 Opium
0.000 0.986 0.014
T37.8 Other specified systemic anti-infectives and antiparasitics
0.000 0.986 0.013
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified
0.000 0.986 0.014
M67.0 Short Achilles tendon (acquired)
0.013 0.986 0.000
T40.1 Heroin
0.000 0.987 0.013
T40.6 Other and unspecified narcotics
0.000 0.987 0.013
T37.9 Systemic anti-infective and antiparasitic, unspecified
0.000 0.987 0.013
T37.5 Antiviral drugs
0.000 0.987 0.013
T37.4 Anthelminthics
0.000 0.987 0.013
T37.3 Other antiprotozoal drugs
0.000 0.987 0.013
T37.2 Antimalarials and drugs acting on other blood protozoa
0.000 0.987 0.013
T37.1 Antimycobacterial drugs
0.000 0.987 0.013
T37.0 Sulphonamides
0.000 0.987 0.013
S02.90 Fracture of skull and facial bones, part unspecified (closed)
0.013 0.987 0.000
N46 Male infertility
0.000 0.987 0.013
T50.7 Analeptics and opioid receptor antagonists
0.000 0.987 0.012
T50.5 Appetite depressants
0.000 0.987 0.012
T50.3 Electrolytic, caloric and water-balance agents
0.000 0.987 0.012
T50.1 Loop [high-ceiling] diuretics
0.000 0.987 0.012
T50.0 Mineralocorticoids and their antagonists
0.000 0.987 0.012
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified
0.000 0.988 0.012
N41.0 Acute prostatitis
0.000 0.988 0.012
T40.4 Other synthetic narcotics
0.000 0.988 0.012
T44 Poisoning by drugs primarily affecting the autonomic nervous system
0.000 0.988 0.012
T49.9 Topical agent, unspecified
0.000 0.988 0.012
T49.8 Other topical agents
0.000 0.988 0.012
T49.7 Dental drugs, topically applied
0.000 0.988 0.012
T49.6 Otorhinolaryngological drugs and preparations
0.000 0.988 0.012
T49.5 Ophthalmological drugs and preparations
0.000 0.988 0.012
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations
0.000 0.988 0.012
T49.3 Emollients, demulcents and protectants
0.000 0.988 0.012
T49.2 Local astringents and local detergents
0.000 0.988 0.012
T49.1 Antipruritics
0.000 0.988 0.012
T41.5 Therapeutic gases
0.000 0.988 0.011
T41.4 Anaesthetic, unspecified
0.000 0.988 0.011
T41.3 Local anaesthetics
0.000 0.988 0.011
T41.1 Intravenous anaesthetics
0.000 0.988 0.011
T41.0 Inhaled anaesthetics
0.000 0.988 0.011
T47 Poisoning by agents primarily affecting gastro-intestinal system
0.000 0.988 0.011
T48.7 Other and unspecified agents primarily acting on the respiratory system
0.000 0.988 0.011
T48.4 Expectorants
0.000 0.988 0.011
T48.3 Antitussives
0.000 0.988 0.011
T48.2 Other and unspecified agents primarily acting on muscles
0.000 0.988 0.011
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]
0.000 0.988 0.011
T48.0 Oxytocic drugs
0.000 0.988 0.011
T50.6 Antidotes and chelating agents, not elsewhere classified
0.000 0.988 0.011
M67.4 Ganglion
0.012 0.988 0.000
S02.00 Fracture of vault of skull (closed)
0.011 0.988 0.000
T48.6 Antiasthmatics, not elsewhere classified
0.000 0.989 0.011
T46 Poisoning by agents primarily affecting the cardiovascular system
0.000 0.989 0.011
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified
0.000 0.989 0.011
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics
0.000 0.989 0.011
T48.5 Anti-common-cold drugs
0.000 0.989 0.011
T36.9 Systemic antibiotic, unspecified
0.000 0.989 0.011
T36.8 Other systemic antibiotics
0.000 0.989 0.011
T36.7 Antifungal antibiotics, systemically used
0.000 0.989 0.011
T36.6 Rifamycins
0.000 0.989 0.011
T36.5 Aminoglycosides
0.000 0.989 0.011
T36.4 Tetracyclines
0.000 0.989 0.011
T36.2 Chloramphenicol group
0.000 0.989 0.011
T36.1 Cefalosporins and other Beta-lactam antibiotics
0.000 0.989 0.011
T36.3 Macrolides
0.000 0.989 0.011
T41.2 Other and unspecified general anaesthetics
0.000 0.989 0.011
M67.9 Disorder of synovium and tendon, unspecified
0.011 0.989 0.000
M67.3 Transient synovitis
0.011 0.989 0.000
S02.60 Fracture of mandible (closed)
0.010 0.990 0.000
T50.9 Other and unspecified drugs, medicaments and biological substances
0.000 0.990 0.010
N41.3 Prostatocystitis
0.000 0.990 0.010
N41.2 Abscess of prostate
0.000 0.990 0.010
N51 Disorders of male genital organs in diseases classified elsewhere
0.000 0.990 0.010
T45.9 Primarily systemic and haematological agent, unspecified
0.000 0.990 0.010
T45.8 Other primarily systemic and haematological agents
0.000 0.990 0.010
T45.7 Anticoagulant antagonists, vitamin K and other coagulants
0.000 0.990 0.010
T45.6 Fibrinolysis-affecting drugs
0.000 0.990 0.010
T45.4 Iron and its compounds
0.000 0.990 0.010
T45.3 Enzymes, not elsewhere classified
0.000 0.990 0.010
N47 Redundant prepuce, phimosis and paraphimosis
0.000 0.990 0.010
T45.2 Vitamins, not elsewhere classified
0.000 0.990 0.010
N41.8 Other inflammatory diseases of prostate
0.000 0.990 0.010
M67.47 Ganglion, ankle and foot
0.010 0.990 0.000
E83.5 Disorders of calcium metabolism
0.000 0.990 0.010
N45 Orchitis and epididymitis
0.000 0.990 0.010
T45.0 Antiallergic and antiemetic drugs
0.000 0.991 0.009
N42.1 Congestion and haemorrhage of prostate
0.000 0.991 0.009
T36.0 Penicillins
0.000 0.991 0.009
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified
0.000 0.991 0.009
S02.11 Fracture of base of skull (open)
0.009 0.991 0.000
D68.5 Primary Thrombophilia
0.000 0.991 0.009
T46.5 Other antihypertensive drugs, not elsewhere classified
0.000 0.991 0.009
T38.9 Other and unspecified hormone antagonists
0.000 0.991 0.009
T38.8 Other and unspecified hormones and their synthetic substitutes
0.000 0.991 0.009
T38.7 Androgens and anabolic congeners
0.000 0.991 0.009
T38.5 Other oestrogens and progestogens
0.000 0.991 0.009
T38.4 Oral contraceptives
0.000 0.991 0.009
T38.2 Antithyroid drugs
0.000 0.991 0.009
T45.5 Anticoagulants
0.000 0.991 0.009
N42 Other disorders of prostate
0.000 0.991 0.009
S42.00 Fracture of clavicle (closed)
0.009 0.991 0.000
T38.1 Thyroid hormones and substitutes
0.000 0.991 0.009
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified
0.000 0.991 0.009
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified
0.000 0.991 0.009
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified
0.000 0.991 0.009
T44.2 Ganglionic blocking drugs, not elsewhere classified
0.000 0.991 0.009
T44.1 Other parasympathomimetics [cholinergics]
0.000 0.991 0.009
T44.0 Anticholinesterase agents
0.000 0.991 0.009
M67.2 Synovial hypertrophy, not elsewhere classified
0.009 0.991 0.000
N44 Torsion of testis
0.000 0.991 0.009
C80.9 Malignant neoplasm, unspecified
0.000 0.991 0.009
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified
0.000 0.991 0.008
T47.8 Other agents primarily affecting the gastro-intestinal system
0.000 0.991 0.008
T47.7 Emetics
0.000 0.991 0.008
T47.6 Antidiarrhoeal drugs
0.000 0.991 0.008
T47.5 Digestants
0.000 0.991 0.008
T47.3 Saline and osmotic laxatives
0.000 0.991 0.008
T45.1 Antineoplastic and immunosuppressive drugs
0.000 0.991 0.008
M67.49 Ganglion, multiple sites
0.008 0.991 0.000
M67.45 Ganglion, hip
0.008 0.991 0.000
T44.9 Other and unspecified drugs primarily affecting the nervous system
0.000 0.991 0.008
D68.8 Other specified coagulation defects
0.000 0.991 0.009
M67.1 Other contracture of tendon (sheath)
0.008 0.991 0.000
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified
0.000 0.992 0.008
T46.9 Other and unspecified agents primarily affecting the cardiovascular system
0.000 0.992 0.008
T46.8 Antivaricose drugs, including sclerosing agents
0.000 0.992 0.008
T46.7 Peripheral vasodilators
0.000 0.992 0.008
T46.0 Cardiac-stimulant glycosides and drugs of similar action
0.000 0.992 0.008
D68 Other coagulation defects
0.000 0.992 0.008
T46.3 Coronary vasodilators, not elsewhere classified
0.000 0.992 0.008
T47.1 Other antacids and anti-gastric-secretion drugs
0.000 0.992 0.008
T47.0 Histamine H(2)-receptor antagonists
0.000 0.992 0.008
T38.0 Glucocorticoids and synthetic analogues
0.000 0.992 0.008
M67.96 Unspecified disorder of synovium and tendon, lower leg
0.008 0.992 0.000
M67.43 Ganglion, wrist
0.008 0.992 0.000
N49 Inflammatory disorders of male genital organs, not elsewhere classified
0.000 0.992 0.008
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs
0.000 0.992 0.008
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified
0.000 0.992 0.008
N51.8 Other disorders of male genital organs in diseases classified elsewhere
0.000 0.992 0.007
N51.1 Disorders of testis and epididymis in diseases classified elsewhere
0.000 0.992 0.007
N51.0 Disorders of prostate in diseases classified elsewhere
0.000 0.992 0.007
T47.2 Stimulant laxatives
0.000 0.993 0.007
T46.2 Other antidysrhythmic drugs, not elsewhere classified
0.000 0.993 0.007
D68.0 Von Willebrand's disease
0.000 0.993 0.007
T47.4 Other laxatives
0.000 0.993 0.007
D68.2 Hereditary deficiency of other clotting factors
0.000 0.993 0.007
N42.8 Other specified disorders of prostate
0.000 0.993 0.007
N51.2 Balanitis in diseases classified elsewhere
0.000 0.993 0.007
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs
0.000 0.993 0.007
T46.4 Angiotensin-converting-enzyme inhibitors
0.000 0.993 0.007
N45.9 Orchitis, epididymitis and epididymo-orchitis without abscess
0.000 0.993 0.007
D68.3 Haemorrhagic disorder due to circulating anticoagulants
0.000 0.993 0.007
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified
0.000 0.993 0.007
N42.3 Dysplasia of prostate
0.000 0.993 0.007
D68.6 Other Thrombophilia
0.000 0.994 0.006
N43 Hydrocele and spermatocele
0.000 0.994 0.006
N45.0 Orchitis, epididymitis and epididymo-orchitis with abscess
0.000 0.994 0.006
N49.1 Inflammatory disorders of spermatic cord, tunica vaginalis and vas deferens
0.000 0.994 0.006
T46.1 Calcium-channel blockers
0.000 0.994 0.006
N49.9 Inflammatory disorder of unspecified male genital organ
0.000 0.994 0.006
N49.0 Inflammatory disorders of seminal vesicle
0.000 0.994 0.006
M20.5 Other deformities of toe(s) (acquired)
0.000 0.994 0.006
D68.1 Hereditary factor XI deficiency
0.000 0.994 0.006
G25.8 Other specified extrapyramidal and movement disorders
0.000 0.994 0.006
S42.0 Fracture of clavicle
0.006 0.994 0.000
C80 Malignant neoplasm without specification of site
0.000 0.994 0.006
H47.2 Optic atrophy
0.005 0.995 0.000
C80.0 Malignant neoplasm, primary site unknown, so stated
0.000 0.995 0.005
M13.00 Polyarthritis, unspecified (Multiple sites)
0.005 0.995 0.000
R16.1 Splenomegaly, not elsewhere classified
0.005 0.995 0.000
N43.1 Infected hydrocele
0.000 0.995 0.005
D68.4 Acquired coagulation factor deficiency
0.000 0.995 0.005
N41.9 Inflammatory disease of prostate, unspecified
0.000 0.995 0.005
S42.01 Fracture of clavicle (open)
0.005 0.995 0.000
N42.2 Atrophy of prostate
0.000 0.995 0.005
M13.0 Polyarthritis, unspecified
0.005 0.995 0.000
N49.2 Inflammatory disorders of scrotum
0.000 0.995 0.005
M13.06 Polyarthritis, unspecified (Lower leg)
0.005 0.995 0.000
T93.2 Sequelae of other fractures of lower limb
0.000 0.995 0.005
K91 Postprocedural disorders of digestive system, not elsewhere classified
0.005 0.995 0.000
N49.8 Inflammatory disorders of other specified male genital organs
0.000 0.995 0.004
N43.0 Encysted hydrocele
0.000 0.995 0.005
T93.9 Sequelae of unspecified injury of lower limb
0.000 0.995 0.005
N42.0 Calculus of prostate
0.000 0.995 0.004
M13.09 Polyarthritis, unspecified (Site unspecified)
0.005 0.995 0.000
N43.2 Other hydrocele
0.000 0.995 0.004
R82.9 Other and unspecified abnormal finding in urine
0.005 0.995 0.000
Z57.2 Occupational exposure to dust
0.004 0.996 0.000
I97.2 Postmastectomy lymphoedema syndrome
0.004 0.996 0.000
G11.9 Hereditary ataxia, unspecified
0.004 0.996 0.000
J20.9 Acute bronchitis, unspecified
0.000 0.996 0.004
H47.0 Disorders of optic nerve, not elsewhere classified
0.004 0.996 0.000
N43.4 Spermatocele
0.000 0.996 0.004
J38.4 Oedema of larynx
0.000 0.996 0.004
M65-M68 Disorders of synovium and tendon
0.004 0.996 0.000
H47 Other disorders of optic [2nd] nerve and visual pathways
0.004 0.996 0.000
S02.10 Fracture of base of skull (closed)
0.004 0.996 0.000
X68.9 Unspecified place
0.000 0.996 0.004
E10.9 Without complications
0.004 0.996 0.000
M66 Spontaneous rupture of synovium and tendon
0.004 0.996 0.000
M66.3 Spontaneous rupture of flexor tendons
0.004 0.996 0.000
G25 Other extrapyramidal and movement disorders
0.000 0.996 0.004
T93 Sequelae of injuries of lower limb
0.000 0.996 0.004
T93.3 Sequelae of dislocation, sprain and strain of lower limb
0.000 0.996 0.004
M13.04 Polyarthritis, unspecified (Hand)
0.004 0.996 0.000
K43.0 Ventral hernia with obstruction, without gangrene
0.004 0.996 0.000
K91.9 Postprocedural disorder of digestive system, unspecified
0.004 0.996 0.000
M13.08 Polyarthritis, unspecified (Other)
0.004 0.996 0.000
M13.07 Polyarthritis, unspecified (Ankle and foot)
0.004 0.996 0.000
M13.05 Polyarthritis, unspecified (Pelvic region and thigh)
0.004 0.996 0.000
M13.03 Polyarthritis, unspecified (Forearm)
0.004 0.996 0.000
M13.02 Polyarthritis, unspecified (Upper arm)
0.004 0.996 0.000
M13.01 Polyarthritis, unspecified (Shoulder region)
0.004 0.996 0.000
T43 Poisoning by psychotropic drugs, not elsewhere classified
0.000 0.996 0.004
E16.2 Hypoglycaemia, unspecified
0.004 0.996 0.000
K91.0 Vomiting following gastro-intestinal surgery
0.004 0.996 0.000
M66.34 Spontaneous rupture of flexor tendons (Hand)
0.003 0.996 0.000
R20.2 Paraesthesia of skin
0.004 0.996 0.000
G24 Dystonia
0.000 0.996 0.004
H47.3 Other disorders of optic disk
0.003 0.996 0.000
G24.5 Blepharospasm
0.000 0.997 0.003
C84.5 Other and unspecified T-cell lymphomas
0.003 0.997 0.000
M66.5 Spontaneous rupture of unspecified tendon
0.003 0.997 0.000
Y44.2 Anticoagulants
0.000 0.997 0.003
K07.4 Malocclusion, unspecified
0.003 0.997 0.000
D68.9 Coagulation defect, unspecified
0.000 0.997 0.003
G24.3 Spasmodic torticollis
0.000 0.997 0.003
C10.9 Oropharynx, unspecified
0.003 0.997 0.000
G11 Hereditary ataxia
0.003 0.997 0.000
M68 Disorders of synovium and tendon in diseases classified elsewhere
0.003 0.997 0.000
M66.31 Spontaneous rupture of flexor tendons (Shoulder region)
0.003 0.997 0.000
G25.9 Extrapyramidal and movement disorder, unspecified
0.000 0.997 0.003
H47.7 Disorder of visual pathways, unspecified
0.003 0.997 0.000
H47.6 Disorders of visual cortex
0.003 0.997 0.000
H47.5 Disorders of other visual pathways
0.003 0.997 0.000
H47.4 Disorders of optic chiasm
0.003 0.997 0.000
M66.37 Spontaneous rupture of flexor tendons (Ankle and foot)
0.003 0.997 0.000
C84.0 Mycosis fungoides
0.003 0.997 0.000
K91.1 Postgastric surgery syndromes
0.003 0.997 0.000
G25.2 Other specified forms of tremor
0.000 0.997 0.003
T93.0 Sequelae of open wound of lower limb
0.000 0.997 0.003
G11.4 Hereditary spastic paraplegia
0.003 0.997 0.000
M66.4 Spontaneous rupture of other tendons
0.003 0.997 0.000
M66.57 Spontaneous rupture of unspecified tendon (Ankle and foot)
0.003 0.997 0.000
G24.9 Dystonia, unspecified
0.000 0.997 0.003
S46.2 Injury of muscle and tendon of other parts of biceps
0.003 0.997 0.000
R82 Other abnormal findings in urine
0.003 0.997 0.000
G25.0 Essential tremor
0.000 0.997 0.003
T43.1 Monoamine-oxidase-inhibitor antidepressants
0.000 0.997 0.003
E70-E90 Metabolic disorders
0.000 0.997 0.003
M66.1 Rupture of synovium
0.003 0.997 0.000
Z95.5 Presence of coronary angioplasty implant and graft
0.000 0.997 0.003
M66.39 Spontaneous rupture of flexor tendons (Site unspecified)
0.003 0.997 0.000
M66.38 Spontaneous rupture of flexor tendons (Other)
0.003 0.997 0.000
M66.36 Spontaneous rupture of flexor tendons (Lower leg)
0.003 0.997 0.000
M66.35 Spontaneous rupture of flexor tendons (Pelvic region and thigh)
0.003 0.997 0.000
M66.33 Spontaneous rupture of flexor tendons (Forearm)
0.003 0.997 0.000
M66.32 Spontaneous rupture of flexor tendons (Upper arm)
0.003 0.997 0.000
M66.30 Spontaneous rupture of flexor tendons (Multiple sites)
0.003 0.997 0.000
G24.8 Other dystonia
0.000 0.997 0.003
G25.6 Drug-induced tics and other tics of organic origin
0.000 0.997 0.003
G25.4 Drug-induced chorea
0.000 0.997 0.003
I73.9 Peripheral vascular disease, unspecified
0.003 0.997 0.000
K91.2 Postsurgical malabsorption, not elsewhere classified
0.003 0.997 0.000
T93.6 Sequelae of crushing injury and traumatic amputation of lower limb
0.000 0.997 0.003
T93.4 Sequelae of injury of nerve of lower limb
0.000 0.997 0.003
C84 Peripheral and cutaneous T-cell lymphomas
0.003 0.997 0.000
K91.5 Postcholecystectomy syndrome
0.003 0.997 0.000
K91.3 Postoperative intestinal obstruction
0.003 0.997 0.000
I97 Postprocedural disorders of circulatory system, not elsewhere classified
0.003 0.997 0.000
I97.8 Other postprocedural disorders of circulatory system, not elsewhere classified
0.003 0.997 0.000
T43.9 Psychotropic drug, unspecified
0.000 0.997 0.003
T43.8 Other psychotropic drugs, not elsewhere classified
0.000 0.997 0.003
E85 Amyloidosis
0.000 0.997 0.003
G25.1 Drug-induced tremor
0.000 0.997 0.003
E73 Lactose intolerance
0.000 0.997 0.003
Z57.5 Occupational exposure to toxic agents in other industries
0.003 0.997 0.000
X68 Intentional self-poisoning by and exposure to pesticides
0.000 0.997 0.003
O63.1 Prolonged second stage (of labour)
0.000 0.997 0.003
R82.7 Abnormal findings on microbiological examination of urine
0.003 0.997 0.000
Z57 Occupational exposure to risk-factors
0.003 0.997 0.000
G24.1 Idiopathic familial dystonia
0.000 0.997 0.003
R82.5 Elevated urine levels of drugs, medicaments and biological substances
0.003 0.997 0.000
R31 Unspecified haematuria
0.000 0.997 0.003
E73.9 Lactose intolerance, unspecified
0.000 0.997 0.003
H47.1 Papilloedema, unspecified
0.003 0.997 0.000
G24.4 Idiopathic orofacial dystonia
0.000 0.997 0.003
G24.2 Idiopathic nonfamilial dystonia
0.000 0.997 0.003
T43.6 Psychostimulants with abuse potential
0.000 0.997 0.003
M66.41 Spontaneous rupture of other tendons (Shoulder region)
0.003 0.997 0.000
E88.0 Disorders of plasma-protein metabolism, not elsewhere classified
0.000 0.997 0.003
G24.0 Drug-induced dystonia
0.000 0.997 0.003
M66.0 Rupture of popliteal cyst
0.003 0.997 0.000
X78.0 Home
0.000 0.997 0.003
C10 Malignant neoplasm of oropharynx
0.003 0.997 0.000
M66.45 Spontaneous rupture of other tendons (Pelvic region and thigh)
0.003 0.997 0.000
M66.59 Spontaneous rupture of unspecified tendon (Site unspecified)
0.002 0.997 0.000
M66.58 Spontaneous rupture of unspecified tendon (Other)
0.002 0.997 0.000
M66.56 Spontaneous rupture of unspecified tendon (Lower leg)
0.002 0.997 0.000
M66.55 Spontaneous rupture of unspecified tendon (Pelvic region and thigh)
0.002 0.997 0.000
M66.54 Spontaneous rupture of unspecified tendon (Hand)
0.002 0.997 0.000
M66.53 Spontaneous rupture of unspecified tendon (Forearm)
0.002 0.997 0.000
M66.52 Spontaneous rupture of unspecified tendon (Upper arm)
0.002 0.997 0.000
M66.51 Spontaneous rupture of unspecified tendon (Shoulder region)
0.002 0.997 0.000
M66.50 Spontaneous rupture of unspecified tendon (Multiple sites)
0.002 0.997 0.000
E85.9 Amyloidosis, unspecified
0.000 0.997 0.003
I42.9 Cardiomyopathy, unspecified
0.000 0.997 0.003
K52.8 Other specified non-infective gastro-enteritis and colitis
0.003 0.997 0.000
C84.4 Peripheral T-cell lymphoma
0.003 0.997 0.000
K91.8 Other postprocedural disorders of digestive system, not elsewhere classified
0.003 0.997 0.000
M66.47 Spontaneous rupture of other tendons (Ankle and foot)
0.003 0.997 0.000
G11.1 Early-onset cerebellar ataxia
0.003 0.997 0.000
G25.5 Other chorea
0.000 0.997 0.003
T43.3 Phenothiazine antipsychotics and neuroleptics
0.000 0.997 0.003
C84.8 Cutaneous T-cell lymphoma, unspecified
0.003 0.997 0.000
G11.8 Other hereditary ataxias
0.003 0.997 0.000
G11.3 Cerebellar ataxia with defective DNA repair
0.003 0.997 0.000
G11.2 Late-onset cerebellar ataxia
0.003 0.997 0.000
G11.0 Congenital nonprogressive ataxia
0.003 0.997 0.000
M68.8 Other disorders of synovium and tendon in diseases classified elsewhere
0.002 0.997 0.000
M68.0 Synovitis and tenosynovitis in bacterial diseases classified elsewhere
0.002 0.997 0.000
M07.36 Other psoriatic arthropathies (Lower leg)
0.003 0.997 0.000
G25.3 Myoclonus
0.000 0.997 0.003
E88 Other metabolic disorders
0.000 0.997 0.003
E85.3 Secondary systemic amyloidosis
0.000 0.997 0.003
I97.9 Postprocedural disorder of circulatory system, unspecified
0.003 0.997 0.000
M07.3 Other psoriatic arthropathies
0.003 0.997 0.000
M07.39 Other psoriatic arthropathies (Site unspecified)
0.003 0.997 0.000
T93.5 Sequelae of injury of muscle and tendon of lower limb
0.000 0.997 0.002
M66.49 Spontaneous rupture of other tendons (Site unspecified)
0.002 0.997 0.000
M66.48 Spontaneous rupture of other tendons (Other)
0.002 0.997 0.000
M66.44 Spontaneous rupture of other tendons (Hand)
0.002 0.997 0.000
M66.43 Spontaneous rupture of other tendons (Forearm)
0.002 0.997 0.000
M66.42 Spontaneous rupture of other tendons (Upper arm)
0.002 0.997 0.000
M66.40 Spontaneous rupture of other tendons (Multiple sites)
0.002 0.997 0.000
M66.2 Spontaneous rupture of extensor tendons
0.002 0.997 0.001
E88.3 Tumour lysis syndrome
0.000 0.997 0.002
R82.6 Abnormal urine levels of substances chiefly nonmedicinal as to source
0.002 0.997 0.000
R82.3 Haemoglobinuria
0.002 0.997 0.000
R82.2 Biliuria
0.002 0.997 0.000
R82.0 Chyluria
0.002 0.997 0.000
S93.0 Dislocation of ankle joint
0.003 0.997 0.000
R82.4 Acetonuria
0.002 0.997 0.000
E75 Disorders of sphingolipid metabolism and other lipid storage disorders
0.000 0.997 0.002
K29.3 Chronic superficial gastritis
0.003 0.997 0.000
X23.9 Unspecified place
0.002 0.997 0.000
E79 Disorders of purine and pyrimidine metabolism
0.000 0.997 0.002
M66.19 Rupture of synovium (Site unspecified)
0.002 0.998 0.000
M66.18 Rupture of synovium (Other)
0.002 0.998 0.000
M66.17 Rupture of synovium (Ankle and foot)
0.002 0.998 0.000
M66.16 Rupture of synovium (Lower leg)
0.002 0.998 0.000
M66.15 Rupture of synovium (Pelvic region and thigh)
0.002 0.998 0.000
M66.14 Rupture of synovium (Hand)
0.002 0.998 0.000
M66.13 Rupture of synovium (Forearm)
0.002 0.998 0.000
M66.12 Rupture of synovium (Upper arm)
0.002 0.998 0.000
M66.11 Rupture of synovium (Shoulder region)
0.002 0.998 0.000
M66.10 Rupture of synovium (Multiple sites)
0.002 0.998 0.000
S46.8 Injury of other muscles and tendons at shoulder and upper arm level
0.002 0.998 0.000
E77 Disorders of glycoprotein metabolism
0.000 0.998 0.002
E76 Disorders of glycosaminoglycan metabolism
0.000 0.998 0.002
E71 Disorders of branched-chain amino-acid metabolism and fatty-acid metabolism
0.000 0.998 0.002
E90 Nutritional and metabolic disorders in diseases classified elsewhere
0.000 0.998 0.002
C84.9 Mature T/NK-cell lymphoma, unspecified
0.002 0.998 0.000
C84.7 Anaplastic large cell lymphoma, ALK-negative
0.002 0.998 0.000
C84.6 Anaplastic large cell lymphoma, ALK-positive
0.002 0.998 0.000
C84.3 Lymphoepithelioid lymphoma
0.002 0.998 0.000
C84.2 T-zone lymphoma
0.002 0.998 0.000
C84.1 Sezary's diease
0.002 0.998 0.000
E80 Disorders of porphyrin and bilirubin metabolism
0.000 0.998 0.002
J20 Acute bronchitis
0.000 0.998 0.002
E85.8 Other amyloidosis
0.000 0.998 0.002
I97.0 Postcardiotomy syndrome
0.002 0.998 0.000
N48.1 Balanoposthitis
0.000 0.998 0.002
Z57.3 Occupational exposure to other air contaminants
0.002 0.998 0.000
E85.2 Heredofamilial amyloidosis, unspecified
0.000 0.998 0.002
E85.1 Neuropathic heredofamilial amyloidosis
0.000 0.998 0.002
E85.0 Nonneuropathic heredofamilial amyloidosis
0.000 0.998 0.002
N42.9 Disorder of prostate, unspecified
0.002 0.998 0.000
E72 Other disorders of amino-acid metabolism
0.000 0.998 0.002
S46 Injury of muscle and tendon at shoulder and upper arm level
0.002 0.998 0.000
G47.1 Disorders of excessive somnolence [hypersomnias]
0.000 0.998 0.002
E74 Other disorders of carbohydrate metabolism
0.000 0.998 0.002
M07.38 Other psoriatic arthropathies (Other)
0.002 0.998 0.000
E73.8 Other lactose intolerance
0.000 0.998 0.002
E73.1 Secondary lactase deficiency
0.000 0.998 0.002
E73.0 Congenital lactase deficiency
0.000 0.998 0.002
E80.1 Porphyria cutanea tarda
0.000 0.998 0.002
N03.9 Unspecified
0.000 0.998 0.002
X68.8 Other specified place
0.000 0.998 0.002
X68.7 Farm
0.000 0.998 0.002
X68.6 Industrial and construction area
0.000 0.998 0.002
X68.5 Trade and service area
0.000 0.998 0.002
X68.4 Street and highway
0.000 0.998 0.002
X68.3 Sports and athletics area
0.000 0.998 0.002
X68.2 School, other institution and public administrative area
0.000 0.998 0.002
X68.1 Residential institution
0.000 0.998 0.002
X68.0 Home
0.000 0.998 0.002
Z57.9 Occupational exposure to unspecified risk-factor
0.002 0.998 0.000
Z57.7 Occupational exposure to vibration
0.002 0.998 0.000
Z57.6 Occupational exposure to extreme temperature
0.002 0.998 0.000
Z57.4 Occupational exposure to toxic agents in agriculture
0.002 0.998 0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

 

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

This website was created, designed, and edited by ORCID iD iconPatrick K. Albers

The contents of TreeWAS.org are available under the Creative Commons Attribution 4.0 International License (CC BY 4.0) with attribution (citation) required.

TreeWAS Database © 2019 - 2024 About Frequently Asked Questions Citation Contact Terms & Conditions This website does not use cookies to collect any personal information about you.